MedTrace Logo

Differential Expression of CD200 in B-chronic Lymphoproliferative Disorders by Multicolour Flow Cytometry

NCT03712488 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2018-10-19

No results posted yet for this study

Summary

The investigator's goals in this study are to assess :

1. Differential expression of CD200 by using flow cytometric immune-phenotyping in broad range of patients with B-chronic lymphoproliferative disorders (B-CLPD)
2. Role of CD200 in diagnosis , classification and potential value in differential diagnosis
3. CD200 expression level at different anatomic sites

Conditions

  • Neoplasms

Interventions

DEVICE

flowcytometry

four colour flowcytometry

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • douaa M Sayed, professor · South Egypt Cancer Institute

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-15
Primary Completion
2020-08-30
Completion
2021-04-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03712488 on ClinicalTrials.gov